Showing 1 - 8 results of 8 for search 'Szarek, M', query time: 0.03s
Refine Results
-
1
-
2
-
3
Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS) by Newman, C, Szarek, M, Demicco, D, Hitman, G, Colhoun, H, Betteridge, D, Durrington, P, Neil, H, Livingston, S, Fuller, J
Published 2006Conference item -
4
The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS). by Newman, C, Szarek, M, Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Demicco, D, Auster, S, Fuller, J
Published 2008Journal article -
5
Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS) by Hitman, G, Newman, C, Szarek, M, Colhoun, H, Betteridge, J, Durrington, P, Neil, A, Livingstone, S, Fuller, J, Investigators, CARDS
Published 2005Conference item -
6
Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS) by Charlton-Menys, V, Betteridge, D, Colhoun, H, Fuller, J, France, M, Hitman, G, Livingstone, S, Neil, H, Newman, C, Szarek, M, Demicco, D, Durrington, P
Published 2009Journal article -
7
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). by Charlton-Menys, V, Betteridge, D, Colhoun, H, Fuller, J, France, M, Hitman, G, Livingstone, S, Neil, H, Newman, C, Szarek, M, DeMicco, D, Durrington, P
Published 2009Journal article -
8
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). by Charlton-Menys, V, Betteridge, D, Colhoun, H, Fuller, J, France, M, Hitman, G, Livingstone, S, Neil, H, Newman, C, Szarek, M, DeMicco, D, Durrington, P
Published 2009Journal article